Deutsch English Français

Contact

EP3008167

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3008167

EP3008167 - COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 11.05.2018 Database last updated on 03.10.2024
Former	Request for examination was made Status updated on 15.01.2018
Most recent event Tooltip	11.05.2018	Application deemed to be withdrawn	published on 13.06.2018 [2018/24]
Applicant(s)	For all designated states VeroScience LLC 1334 Main Road Tiverton RI 02878 / US
	[2016/16]
Inventor(s)	01 / CINCOTTA, Anthony, H. 1334 Main Road Tiverton Rhode Island 02878 / US
	02 / ZHANG, Yahong 31 Tupelo Road Westport Massachusetts 02790 / US
	[2016/19]
Former [2016/16]	01 / CINCOTTA, Anthony, H. 1334 Main Road Tiverton Rhode Island 02878 / US
	02 / ZHANG, Yahong Westport Massachusetts 02790 / US
Representative(s)	Zacco Denmark A/S Arne Jacobsens Allé 15 2300 Copenhagen S / DK
	[2016/16]
Application number, filing date	14811295.6	13.06.2014
	[2016/16]
	WO2014US42397
Priority number, date	US201361834864P	13.06.2013 Original published format: US 201361834864 P
	[2016/16]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2014201411
	Date:	18.12.2014
	Language:	EN
	[2014/51]
	Type:	A1 Application with search report
	No.:	EP3008167
	Date:	20.04.2016
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 18.12.2014 takes the place of the publication of the European patent application.
	[2016/16]
Search report(s)	International search report - published on:	US	18.12.2014
	(Supplementary) European search report - dispatched on:	EP	09.05.2017
Classification	IPC:	C12N5/00, A61K45/06, A61K31/42, A61K31/498, A61P3/10, A61P9/10, A61P5/50	[2017/09]
	CPC:	A61K31/498 (EP,US); A61K31/198 (US); A61K31/42 (EP,US); A61K45/06 (EP,US); A61P25/00 (US); A61P3/10 (EP,US); (+) A61P5/50 (EP,US); A61P9/10 (EP,US) (-)
	Former IPC [2016/16]	C12N5/00
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/16]
Extension states	BA	04.01.2016
	ME	04.01.2016
Title	German:	ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN	[2016/16]
	English:	COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS	[2016/16]
	French:	COMPOSITIONS ET MÉTHODES POUR LE TRAITEMENT DES TROUBLES MÉTABOLIQUES	[2016/16]
Entry into regional phase	04.01.2016	National basic fee paid
	04.01.2016	Search fee paid
	04.01.2016	Designation fee(s) paid
	04.01.2016	Examination fee paid
Examination procedure	04.01.2016	Examination requested [2016/16]
	02.08.2016	Amendment by applicant (claims and/or description)
	09.12.2017	Application deemed to be withdrawn, date of legal effect [2018/24]
	16.01.2018	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/24]
Divisional application(s)	EP17206128.5 / EP3311842
Fees paid	Renewal fee
	27.06.2016	Renewal fee patent year 03
	27.06.2017	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]WO02089848 (LILLY CO ELI [US], et al) [X] 1-12,16-18 * abstract *;
		[X]WO2008148836 (GLAXO GROUP LTD [GB], et al) [X] 1-12,16-18 * page 1, line 1 - line 5 * * page 11, line 30 - page 12, line 29 *;
		[X]WO2009053448 (GLAXO GROUP LTD [GB], et al) [X] 1-12,16-18 * page 1, line 1 - line 6 * * page 24, line 1 - line 41 *;
		[X]WO2009053449 (GLAXO GROUP LTD [GB], et al) [X] 1-12,16-18 * page 1, line 1 - line 6 ** page 14, line 40 - page 15, line 37 *;
		[X]WO2010057865 (GLAXO GROUP LTD [GB], et al) [X] 1-12,16-18 * page 1, line 1 - line 6 * * page 9, line 34 - page 10, line 32 *;
		[X]WO2010066658 (GLAXO GROUP LTD [GB], et al) [X] 1-12,16-18 * page 1, line 1 - line 6 * * page 10, line 24 - page 11, line 23 *;
		[X]US2011021584 (BERGGREN PER-OLOF [US], et al) [X] 1-12,16-18 * paragraphs [0009] - [0013] *;
		[X]WO2012020848 (TAKEDA PHARMACEUTICAL [JP], et al) [X] 1-12,16-18 * paragraphs [0001] , [0256] *
	International search	[Y]US2005245612 (BLASS JOHN P [US]);
		[Y]US2007129312 (YATVIN MILTON B [US], et al);
		[Y]US2008200453 (CINCOTTA ANTHONY H [US]);
		[Y]US2009305225 (GALBRAITH RICHARD A [US]);
		[Y]WO2010015037 (HOWARD FLOREY INST [AU], et al);
		[X]US2012148499 (TSIEN ROGER Y [US], et al);
		[Y]US2012283193 (SPITZER NICHOLAS C [US], et al);
		[X] - LAM CK ET AL., "Activation of N-methyl-D-aspartate (NMDA) receptors in the dorsal vagal complex lowers glucose production", J BIOL CHEM., (20100716), vol. 285, no. 29, pages 21913 - 21, XP055302315 DOI: http://dx.doi.org/10.1074/jbc.M109.087338
		[Y] - CARRANZA ET AL., "I-Dopa uptake and dopamine production in proximal tubular cells are regulated by ?2-adrenergic receptors.", AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, (2000), vol. 279, no. 1, pages F77 - F83, XP055302316

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p